Company or institution

NOVARTIS AG

Save Like

4,320 applicationsfiled 2006 to 2026

Allowance rate

57%

−18 pts vs the USPTO range 55% to 59%

Rejections before allowance

1.5

level with the USPTO

Months to first action

15.7 mo

−2.9 vs the USPTO

Needed an RCE

25%

−2 pts vs the USPTO

Timeline

Applications by filing year: drag across the years to study a period

Allowed in green, abandoned in red, pending in grey. The figures above and the charts that can be recomputed by filing year follow the span you pick.

Compared with the office

Against every applicant before the USPTO

Unlock the comparison with the officeFree with an account. No card needed.

Create a free account

Trend

Allowance by filing year

Unlock the trendIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Domains

Where the applications fall

CPC subclasses

A61K Medical preparations1,627 apps

C07D Heterocyclic compounds922 apps

C07K Peptides409 apps

A61F 280 apps

A61B Diagnosis, surgery, identification175 apps

A61P Therapeutic activity of compounds117 apps

Art units

1624382 apps

1626281 apps

1628225 apps

1625212 apps

1627201 apps

1629165 apps

Examiners met

The examiners seen most, and how it went with each

Docket Central99 apps

Deepak R Rao48 apps

69%

Douglas M Willis44 apps

77%

Brian E McDowell42 apps

64%

Samantha L Shterengarts41 apps

76%

San Ming R Hui39 apps

21%

Susanna Moore37 apps

53%

Anna Pagonakis37 apps

19%

Bars show the share of decided applications that were allowed.

Unlock the examiners this company meetsIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Who represents them

Law firms and agents on their applications

NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC.1,390 apps

59%

NOVARTIS PHARMACEUTICAL CORPORATION860 apps

44%

ALCON INC.558 apps

67%

ALCON RESEARCH, LLC247 apps

73%

GENOMICS INSTITUTE OF THE117 apps

78%

NOVARTIS VACCINES85 apps

28%

K&L Gates - Novartis75 apps

51%

Paul D. Strain75 apps

31%

Bars show the share of decided applications that were allowed.

Unlock the firms on their applicationsIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Rejection fingerprint

What gets rejected, by statute

Share of parsed office actions raising each ground; blue is the USPTO.

Unlock the rejection fingerprintIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

What works

Allowance by strategy used

Unlock what works for this filerIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Interviews

Does an interview help?

Unlock the interview figuresFree with an account. No card needed.

Create a free account

Applications

Every application in the record

Application	Title	Filed	Status	Rejections	RCEs	To 1st action
19883593	MACROCYCLIC PANRAS INHIBITORS FOR THE TREATMENT OF CANCER	2026-10-08	Pending	0	0	n/a
19882857	PHARMACEUTICAL COMBINATIONS AND USES THEREOF	2026-10-07	Pending	0	0	n/a
19618526	RAPCABTAGENE AUTOLEUCEL FOR USE IN TREATING SYSTEMIC LUPUS ERYTHEMATOSUS	2026-08-26	Pending	0	0	n/a
15961839	Method and apparatus for adaptive signal processing	2012-01-10	Allowed	1	0	12.0 mo
15100853	Composition and method for controlled release	2015-02-11	Abandoned	4	1	23.0 mo
15838227	Distributed ledger transaction verification	2018-03-12	Allowed	3	0	20.0 mo
15777761	Thermal management of battery assemblies	2021-04-13	Pending	2	1	17.0 mo
15961439	Machine learning model for anomaly detection	2012-05-14	Allowed	1	0	14.0 mo
15720958	Wireless power transfer coil arrangement	2015-06-15	Abandoned	4	1	25.0 mo
15645631	Catalyst for selective hydrogenation	2018-07-16	Allowed	3	0	22.0 mo

Unlock all 4,320 applications, each with its full timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in